[Table/Fig-3]:

Studies depicting effects of etanercept in treatment of RAS.

STUDY	SUBJECTS	TREATMENT	EFFECTS
Robinson ND et al., (2003) [35]	50-year-old woman with a 24-year history of RAS.	Etanercept (25 mg twice weekly, subcutaneous).	Significant improvement in RAS within 1 month.
Hasan A et al., (2013) [37]	Patients with RAS associated with celiac disease.	Etanercept (25 mg twice weekly, subcutaneous).	Complete remission.
Gonzalez-Lopez MA et al., (2013) [38]	A 34-year-old man suffering from RAS since 15-years, unresponsive to treatment.	Etanercept (25mg twice weekly).	Significant clinical improvement seen after 4 weeks of therapy.